Merck Non-Current Deferred Revenue (Quarterly) Analysis

Merck & Co., Inc. (MRK)

109.22 -1.30 (-1.18%) USD | NYSE | Jan 12, 16:00

109.19 -0.04 (-0.03%) After-Hours: 20:00

View Non-Current Deferred Revenue (Quarterly) for MRK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Cidara Therapeutics, Inc.	--
Moderna, Inc.	Upgrade